🇺🇸 FDA

Intelligence Platform

Patents

Browse 252 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8163509

Biological markers predictive of anti-cancer response to insulin-like growth factor-1 rece

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8138312

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093286

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080578

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8057807

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus in

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017321

Gefitinib sensitivity-related gene expression and products and methods related thereto

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7976851

Non-toxic biofilm inhibitor

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678824

Methods for treatment with bucindolol based on genetic targeting

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560265

Compositions for regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361355

Mutant forms of cholera holotoxin as an adjuvant

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285281

Mutant forms of cholera holotoxin as an adjuvant

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted